Member Info for Hertstrader74

Then the only reason for the subdued share price has to be the placing and churn since mid November. Now that is coming to an end and given volumes of late it does seem a decent rerate in on the cards. Would be nice to climb to 0.4/0.5 and hold that even then would only give us a market cap of between 12 and 15 million quid

I know we have recently had a placing at 0.2p but to me the market cap at a bit over 8 million looks far to undervalued for me. With continued successes up gold pouring to come and news on other assets I would be looking short term of a market cap around 25 million

according to the RNS 30th Dec they had 111 million shares left (and i pressume a fair amount of warrants)
with the volumes of late i am taking a punt that the placing shares have been cleared, and now just a case of flushing out the warrants as and when they get exercised

still my buy of 2.7million yet to show

I bought back in here just now but trade not showing. 2735025 shares at 0.278p. I was waiting for signs of the placing being cleared. Looks very positive and love they just poured the first gold

2.9p about to go. Gone NT for me to buy

I think the 350 million warrants are at 0.9p

Bang. Those block 2 and 2.5 million sells looks like that’s over 10 million more placing stock flipped. Back under 0.52 to buy again

Nice to see new investors and some big buys today. I do think we still have some placing churn which is putting the breaks on at present but for only a market cap of 7 million this does look significantly undervalued

I can only get a quote to but 250k online.

so despite confirmation today, why is the market cap only 7 million??

clearly any potential move on today's RNS was hindered by the placing shares

how much of the overhang do you all think is left, i presume that recent 2.5 million sell is part of the overhang being churned?? I would imagine the buying pressure of the next two weeks will quickly flip the remaining overhang and a climb to 0.8p over the next couple of weeks is not out of the question>>

i would say all covid stocks have risen since new year, except N4P, Green stocks flying, Bitcoin Stocks flying, N4P dropping, 5% below cheap placing price, mainly because traders were expecting news on Monday and silence, selling out and investing elsewhere. Despite recent placing this share has relatively few shares in issue, so a few 100k k sells (or buys) can have a dramatic effect on the SP short term. Trying to find some cash to top up at these crazy low levels, but it did dip to 7.3p a week before christmas before going over 9p a day or so later

[less then 14 million market cap, still amazed at the lack of patience of investors, why sell under the placing price with so much potential to come this year? i suppose it makes a top up even cheaper

i agree, this needs news pretty quick as the buyers have dried up and we are starting to drift

yep that is good news, just need some news here to light the touch paper, took a few more at 8p

National lockdown announced. Swill be interesting to see what the markets do tomorrow. Now would be a good time for a decent update

Taken from 5th November RNS

Feasibility work continues on Nuvec® as a solution to the challenges faced in the delivery of vaccines orally. The Company expects to have some data following the results of planned studies as to its viability towards the end of this year. Development of an orally administered vaccine has significantly greater challenges than a subcutaneous injection. One important aspect is that the DNA plasmid may be subject to damage and breakdown by gastric acid and other digestive processes. However, the Company has now demonstrated that Nuvec® protects plasmid DNA from both acid and nuclease digestion. This result gives the Company confidence that further investigation of this route of administration using Nuvec® is merited.



Nigel Theobald, Chief Executive Officer of the Company, commented:



"We are pleased to have made significant strides with our optimisation work and are currently analysing the findings. We are examining how these will feed into the optimised strand of the pending in vivo study. The unoptimised side of this, which involves our first full in vivo study utilising the Coronavirus DNA plasmid, is due to commence imminently.



"Taken together with the work into oral applications and the ongoing technology transfer for the manufacture of Nuvec®, we are entering a pivotal time for the Company over the next six months and I look forward to providing further updates as each work stream progresses."

Good old N4P start the year with a red day, I still think we are seeing some churn from the placing, looks like another strict lockdown coming, you would think N4P would be hoping for collaboration asap. This is probably the one Covid stock not to have risen today?
What is this new Asset to their portfolio they are looking at as per the placing RNS?

Just seems to cheap a market cap at the moment and we do need some news to dot the I's and cross the T's